89bio (ETNB) Earnings Date & Reports

A.I. Advisor
published Earnings

ETNB is expected to report earnings to rise 2.44% to -55 cents per share on August 08

89bio ETNB Stock Earnings Reports
Q2'24
Est.
$-0.55
Q1'24
Missed
by $0.08
Q4'23
Missed
by $0.01
Q3'23
Beat
by $0.08
Q2'23
Missed
by $0.06
The last earnings report on May 09 showed earnings per share of -54 cents, missing the estimate of -45 cents. With 654.77K shares outstanding, the current market capitalization sits at 821.51M.
View a ticker or compare two or three
ETNB
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
142 Sansome Street
Phone
+1 415 432-9270
Employees
70
Web
https://www.89bio.com